TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
VIR

Vir Biotechnology Inc

Healthcare · Biotechnology

11.20$ +2.0% vs. previous close Closing price · As of: Nov 3, 2026

Statements

Income Statement

Vir Biotechnology Inc (VIR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 69 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VIR
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
2.7 11 0.7 76 1,095 1,616 86 74 69
63 100 143 302 72 162 22 15 12
-62 -99 0.7 76 1,024 1,454 64 59 57
62 97 148 302 442 468 551 463 433
22 29 38 71 161 162 174 119 92
83 127 179 373 603 621 725 582 525
-81 -119 -178 -297 421 833 -661 -523 -468
0.0 0.0 8.0 3.8 273 183 – – –
-81 -116 -175 -299 550 754 -628 -523 -438
-11 -0.5 0.2 -0.1 21 238 -13 -1.1 0.2
-70 -116 -175 -299 529 516 -615 -522 -438
-80 -116 -173 514 433 849 -642 -509 -456

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?